(Q34375582)

1 August 2017

title

Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin (English)

1 reference

1 August 2017

main subject

ascending cholangitis

0 references

ulcerative colitis

1 reference

inferred from title

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

3

Tremaine WJ

1 reference

1 August 2017

Sandborn WJ

1

1 reference

1 August 2017

Wiesner RH

series ordinal

2

1 reference

1 August 2017

Larusso NF

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

1 August 2017

1 reference

1 August 2017

volume

34

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

242-246

1 reference

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Cyclosporine therapy for pyoderma gangrenosum associated with sclerosing cholangitis and ulcerative colitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Treatment of Crohn's disease in relapse with cyclosporin A.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Cyclosporin for Crohn's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Cyclosporine treatment of autoimmune chronic active hepatitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Cell-mediated immunity in gastrointestinal disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Cyclosporin A treatment in inflammatory bowel disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Treatment of chronic proctosigmoiditis with cyclosporin enemas.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Low-dose cyclosporin for Crohn's disease: implications for clinical trials.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1373978

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

27 October 2018

1 reference

12 December 2020

Primary sclerosing cholangitis: a long-term follow-up study

1 reference

12 December 2020

Prospective serial renal function studies in patients with nonrenal disease treated with cyclosporine A

1 reference

12 December 2020

Treatment of refractory ulcerative colitis with cyclosporin enemas

1 reference

12 December 2020

Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease

1 reference

12 December 2020

Effects of cyclosporin A on active Crohn's disease

1 reference

12 December 2020

Cyclosporine treatment of fulminant colitis

1 reference

12 December 2020

A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Preliminary report: cyclosporin in treatment of severe active ulcerative colitis

1 reference

12 December 2020

Cyclosporin treatment for severe active ulcerative colitis

1 reference

12 December 2020

VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS

1 reference

12 December 2020

Clinicopathologic features of the syndrome of primary sclerosing cholangitis

1 reference

12 December 2020

Liquid-chromatographic determination of cyclosporin A in blood and plasma

1 reference

12 December 2020

Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF

1 reference

12 December 2020

Sclerosing cholangitis in ulcerative colitis. A follow-up study

1 reference

12 December 2020

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

1 reference

12 December 2020

Side effects of systemic cyclosporine in patients not undergoing transplantation

1 reference

12 December 2020

Cyclosporin in ulcerative colitis

1 reference

12 December 2020

Cyclosporine improves psoriasis in a double-blind study

1 reference

12 December 2020

Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis

1 reference

12 December 2020

Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.34.2.242

1 reference

1 August 2017

1 reference

1 August 2017

1 reference